The estimated Net Worth of James L. Cunniff is at least $176 Tausend dollars as of 1 March 2024. James Cunniff owns over 9,000 units of Electromed stock worth over $176,400 and over the last few years James sold ELMD stock worth over $0.
Sign up
James Cunniff ELMD stock SEC Form 4 insiders trading
James has made over 2 trades of the Electromed stock since 2023, according to the Form 4 filled with the SEC. Most recently James bought 9,000 units of ELMD stock worth $137,250 on 1 March 2024.
The largest trade James's ever made was buying 9,000 units of Electromed stock on 1 March 2024 worth over $137,250. On average, James trades about 2,500 units every 25 days since 2023. As of 1 March 2024 James still owns at least 10,000 units of Electromed stock.
You can see the complete history of James Cunniff stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's James Cunniff's mailing address?
James's mailing address filed with the SEC is 500 SIXTH AVENUE NW, , NEW PRAGUE, MN, 56071.
Insiders trading at Electromed
Over the last 14 years, insiders at Electromed have traded over $2,585,226 worth of Electromed stock and bought 684,801 units worth $2,582,707 . The most active insiders traders include Oak Partners, Llc Red, Stephen H. Craney und Kathleen Skarvan. On average, Electromed executives and independent directors trade stock every 84 days with the average trade being worth of $358,798. The most recent stock trade was executed by James L. Cunniff on 1 March 2024, trading 9,000 units of ELMD stock currently worth $137,250.
What does Electromed do?
electromed, inc. is a minnesota-based company (nyse mkt: elmd) and the innovative leader in the development, manufacture, and worldwide sales of the smartvest® airway clearance system. the patented system uses high frequency chest wall oscillation (hfcwo), a better-tolerated alternative to chest physiotherapy (cpt), to deliver vigorous, yet comfortable airway clearance treatment for patients battling the consequences of retained secretions. hfcwo has been clinically proven to clear the lungs of excess mucus, improve and reduce lung infections for individuals suffering from various conditions including atelectasis, copd, bronchiectasis, neuromuscular diseases, and cystic fibrosis. electromed, inc. is accredited by the joint commission and is iso 13485:2003 and iso 9001:2008 certified.
What does Electromed's logo look like?
Complete history of James Cunniff stock trades at Electromed
Electromed executives and stock owners
Electromed executives and other stock owners filed with the SEC include:
-
Kathleen Skarvan,
President, Chief Executive Officer, Director -
Kathleen S. Skarvan,
CEO, Pres & Director -
Michael Joseph MacCourt,
Chief Fin. Officer -
Stephen Craney,
Independent Chairman of the Board -
Michael MacCourt,
Chief Financial Officer -
Stan Erickson,
Independent Director -
Gregory Fluet,
Independent Director -
Lee Jones,
Independent Director -
George Winn,
Independent Director -
Andrea Walsh,
Independent Director -
Kalle Ahl,
IR Contact Officer -
Kathryn Thompson,
VP of Reimbursement -
William J. George,
Sec. -
Bud Reeves,
VP of Sales -
William Eckles,
Director -
Jeremy T. Brock,
Chief Financial Officer -
Oak Partners, Llc Red,
10% owner -
John L Erb,
Director -
Craig N. Hansen,
Director -
James J. Cassidy,
Chief Operating Officer -
Darrel L Kloeckner,
Director -
Terry M. Belford,
Chief Financial Officer -
Thomas M. Hagedorn,
Director -
Robert D. Hansen,
Chief Executive Officer -
Andrew Summers,
Director -
Bradley M. Nagel,
Chief Financial Officer -
Christopher G. Holland,
Chief Commercial Officer -
Kathleen A Tune,
Director -
Joseph L. Galatowitsch,
Director -
Michelle C. Wirtz,
Chief Financial Officer -
James L. Cunniff,
CEO and President